We then examined whether this methylation pattern was exclusive to the TNBC subtype or common to other BC subtypes by interrogating the TNBC methylation signature in a series of Luminal A, Luminal B/HER2-negative, Luminal B/HER2-positive and HER2-positive BC patients (eight per group). The gene discussed is ERBB2; the disease is breast cancer.